GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bausch Health Companies Inc (XSWX:VRX) » Definitions » Cyclically Adjusted PB Ratio

Bausch Health (XSWX:VRX) Cyclically Adjusted PB Ratio : (As of Apr. 29, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Bausch Health Cyclically Adjusted PB Ratio?

Note: If the price history is too short, we do not calculate current Cyclically Adjusted PB Ratio for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


Bausch Health Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Bausch Health's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bausch Health Cyclically Adjusted PB Ratio Chart

Bausch Health Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.35 1.72 2.45 0.63 0.92

Bausch Health Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.63 0.83 0.84 0.92 0.92

Competitive Comparison of Bausch Health's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Bausch Health's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bausch Health's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bausch Health's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Bausch Health's Cyclically Adjusted PB Ratio falls into.



Bausch Health Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Bausch Health's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Bausch Health's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book=Book Value per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-2.487/125.4675*125.4675
=-2.487

Current CPI (Dec. 2023) = 125.4675.

Bausch Health Quarterly Data

Book Value per Share CPI Adj_Book
201403 13.437 98.604 17.098
201406 14.112 99.473 17.800
201409 14.371 99.394 18.141
201412 15.398 98.367 19.640
201503 18.471 99.789 23.224
201506 17.500 100.500 21.847
201509 17.977 100.421 22.461
201512 17.150 99.947 21.529
201603 16.176 101.054 20.084
201606 14.968 102.002 18.411
201609 11.665 101.765 14.382
201612 9.238 101.449 11.425
201703 11.208 102.634 13.702
201706 10.919 103.029 13.297
201709 14.709 103.345 17.858
201712 16.555 103.345 20.099
201803 12.010 105.004 14.351
201806 9.818 105.557 11.670
201809 8.729 105.636 10.368
201812 7.748 105.399 9.223
201903 7.657 106.979 8.980
201906 7.295 107.690 8.499
201909 6.977 107.611 8.135
201912 2.963 107.769 3.450
202003 1.945 107.927 2.261
202006 1.270 108.401 1.470
202009 1.513 108.164 1.755
202012 1.337 108.559 1.545
202103 -0.515 110.298 -0.586
202106 -1.755 111.720 -1.971
202109 -0.530 112.905 -0.589
202112 -0.275 113.774 -0.303
202203 -0.565 117.646 -0.603
202206 -1.892 120.806 -1.965
202209 -1.438 120.648 -1.495
202212 -1.814 120.964 -1.882
202303 -2.083 122.702 -2.130
202306 -1.680 124.203 -1.697
202309 -2.987 125.230 -2.993
202312 -2.487 125.468 -2.487

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Bausch Health  (XSWX:VRX) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Bausch Health Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Bausch Health's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Bausch Health (XSWX:VRX) Business Description

Traded in Other Exchanges
Address
2150 Saint Elzear Boulvard West, Laval, QC, CAN, H7L 4A8
Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.

Bausch Health (XSWX:VRX) Headlines

No Headlines